Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome

Dinu S Chandran1, Ashok Kumar Jaryal, Viveka P Jyotsna

  • 1Department of Physiology, All India Institute of Medical Sciences, Ansari Nagal, New Delhi, India.

Endocrine Journal
|July 23, 2011
PubMed

Insights

Endogenous Cushing's syndrome impairs vascular reactivity and endothelial function. Elevated cortisol levels are linked to this dysfunction, increasing cardiovascular risks.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • Endogenous Cushing's syndrome (CS) is linked to high cardiovascular morbidity and mortality.
  • Multiple cardiovascular risk factors in CS likely induce endothelial dysfunction.
  • Emerging evidence suggests cortisol directly contributes to vascular dysfunction in CS.

Purpose of the Study:

  • To non-invasively assess vascular reactivity in CS patients.
  • To investigate the association between vascular reactivity and elevated cortisol levels in CS.
  • To explore the role of hypercortisolism in endothelial dysfunction in CS.

Main Methods:

  • Observational study comparing 18 CS patients with 15 healthy controls.
  • Non-invasive assessment of vascular reactivity using digital photoplethysmography (PPG) during reactive hyperemia (RH).
  • Measured pulse wave form amplitude (PWA) and pulse transit time (PTT) changes.

Main Results:

  • Maximal PWA changes during RH were significantly lower in CS patients versus controls (p=0.0079).
  • Normalized PTT responses during the first minute of RH were blunted in CS patients (p=0.0425).
  • PTT changes during the second minute of RH negatively correlated with morning cortisol levels (r=-0.6328, p=0.0064).

Conclusions:

  • Endothelium-mediated vascular reactivity and myogenic regulation of vascular tone are impaired in CS.
  • Hypercortisolism likely plays a significant role in causing impaired vascular reactivity and endothelial dysfunction in CS.
  • These findings highlight potential therapeutic targets for cardiovascular risk reduction in CS.

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...